ADAM10 and Alzheimer disease: The human ADAM10 promoter contains two retinoic acid response elements and ADAM expression can be upregulated at the transcriptional level by the vitamin A analog acitretin in cells and in transgenic AD mouse models leading to increased APPsα and reduced Aβ production (Tippmann et al., 2009).